Economic portfolio
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND
ABSL Aditya Birla Sun Life Mutual Fund Jan 2022 — Sep 2026 57 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 3.5 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
57 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
55.6% now, 56.2% in Sep 2025 · highest 72.3%, lowest 53.3%
Companies held
39 now, 36 in Sep 2025 · largest single holding 9.5% of equity
How long new positions last: of the 29 companies this fund started holding between Jun 2022 and Aug 2025, 97% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →
How it trades: no clear lean toward recent winners or losers (score +0.02 over 8 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- NIPPON INDIA PHARMA FUNDNippon India · 28 shared65.3%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 26 shared57.5%
- Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 20 shared56.6%
- EODWHFEdelweiss · 18 shared54.9%
- Mirae Asset Healthcare FundMirae Asset · 18 shared54.4%
- Bandhan BSE Healthcare Index FundBandhan · 36 shared54.3%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 36 shared54.3%
- WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 23 shared53.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- None this month.
Complete exits
- None this month.
Largest increases
Largest reductions
- None this month.
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 9.47% | 99.97 Cr | 0.02 Cr | by Jan 2022 (57 mo+) |
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 8.79% | 92.79 Cr | 0.05 Cr | by Jan 2022 (57 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 6.57% | 69.35 Cr | 84,936 | by Jan 2022 (57 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.51% | 68.71 Cr | 0.05 Cr | by Jan 2022 (57 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.61% | 48.70 Cr | 0.03 Cr | by Jan 2022 (57 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 4.58% | 48.36 Cr | 0.03 Cr | Dec 2024 (22 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 4.44% | 46.82 Cr | 0.01 Cr | by Jan 2022 (57 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 3.69% | 38.95 Cr | 0.02 Cr | Apr 2023 (42 mo) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 3.58% | 37.77 Cr | 0.02 Cr | Apr 2026 (6 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 3.32% | 35.08 Cr | 12,933 | by Jan 2022 (57 mo+) |
| Emcure Pharmaceuticals Limited | Healthcare | Small Cap | 3.27% | 34.54 Cr | 0.02 Cr | Jul 2024 (27 mo) |
| Lupin Limited | Healthcare | Mid Cap | 3.01% | 31.71 Cr | 0.02 Cr | by Jan 2022 (57 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.77% | 29.20 Cr | 0.02 Cr | Sep 2024 (25 mo) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.76% | 29.14 Cr | 0.01 Cr | Jul 2025 (15 mo) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.47% | 26.10 Cr | 0.03 Cr | by Jan 2022 (57 mo+) |
| CORONA Remedies Limited | Not classified | Small Cap | 2.32% | 24.49 Cr | 0.01 Cr | Dec 2025 (10 mo) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 2.29% | 24.16 Cr | 26,000 | May 2025 (17 mo) |
| Procter & Gamble Health Limited | Healthcare | Small Cap | 1.86% | 19.58 Cr | 35,195 | Nov 2024 (23 mo) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 1.79% | 18.94 Cr | 0.04 Cr | Jun 2025 (16 mo) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 1.71% | 18.09 Cr | 35,039 | by Jan 2022 (57 mo+) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 1.58% | 16.66 Cr | 0.07 Cr | Sep 2023 (37 mo) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 1.51% | 15.91 Cr | 0.03 Cr | Feb 2025 (20 mo) |
| Biocon Limited | Healthcare | Mid Cap | 1.48% | 15.63 Cr | 0.04 Cr | Jun 2025 (16 mo) |
| Shilpa Medicare Limited | Healthcare | Small Cap | 1.46% | 15.39 Cr | 0.01 Cr | Jul 2025 (15 mo) |
| Piramal Pharma Limited | Healthcare | Small Cap | 1.25% | 13.18 Cr | 0.06 Cr | Aug 2025 (14 mo) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 1.16% | 12.20 Cr | 98,975 | by Jan 2022 (57 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 1.15% | 12.16 Cr | 0.01 Cr | Mar 2026 (7 mo) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 1.14% | 12.00 Cr | 31,557 | Mar 2025 (19 mo) |
| Suraksha Diagnostic Limited | Not classified | Small Cap | 1.13% | 11.90 Cr | 0.03 Cr | Nov 2024 (23 mo) |
| Manipal Health Enterprises Limited | Not classified | — | 1.09% | 11.50 Cr | 0.02 Cr | Jul 2026 (3 mo) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 1.07% | 11.24 Cr | 78,210 | by Jan 2022 (57 mo+) |
| Pfizer Limited | Healthcare | Small Cap | 1.03% | 10.87 Cr | 28,058 | Aug 2025 (14 mo) |
| Natco Pharma Limited | Healthcare | Small Cap | 0.94% | 9.93 Cr | 0.01 Cr | Aug 2026 (2 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 0.85% | 8.97 Cr | 32,390 | Feb 2025 (20 mo) |
| Medi Assist Healthcare Services Limited | Not classified | Small Cap | 0.75% | 7.90 Cr | 0.03 Cr | Jan 2024 (33 mo) |
| Vinati Organics Limited | Not classified | Small Cap | 0.71% | 7.47 Cr | 63,971 | Dec 2022 (46 mo) |
| Syngene International Limited | Healthcare | Small Cap | 0.65% | 6.91 Cr | 0.02 Cr | Jun 2026 (4 mo) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 0.62% | 6.51 Cr | 70,000 | May 2025 (17 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 0.62% | 6.49 Cr | 63,087 | Jul 2025 (15 mo) |
Half of its current holdings have been held for 23 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Cipla Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Biocon Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +70,339 |
| Shilpa Medicare Limited | Aug 2026 | ▼ Reducing | -0.03 Cr |
| Natco Pharma Limited | Aug 2026 | ▲ New position | +0.01 Cr |
| Cipla Limited | Aug 2026 | ▲ Increasing | +72,000 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▼ Reducing | -15,261 |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -0.02 Cr |
| Manipal Health Enterprises Limited | Jul 2026 | ▲ New position | +0.02 Cr |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▼ Reducing | -0.01 Cr |
| Cipla Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Biocon Limited | Jul 2026 | ▲ Increasing | +45,564 |
| Sai Life Sciences Limited | Jul 2026 | ▲ Increasing | +30,737 |
| Metropolis Healthcare Limited | Jul 2026 | ▲ Increasing | +25,000 |
| Dr. Lal Path Labs Ltd. | Jul 2026 | ▲ Increasing | +22,000 |
| Syngene International Limited | Jun 2026 | ▲ New position | +0.02 Cr |
| Alembic Pharmaceuticals Limited | Jun 2026 | ▼ Complete exit | -0.02 Cr |
| Shilpa Medicare Limited | Jun 2026 | ▼ Reducing | -0.01 Cr |
| Sai Life Sciences Limited | Jun 2026 | ▲ Increasing | +0.01 Cr |
| Gland Pharma Limited | Jun 2026 | ▲ Increasing | +50,000 |
| Vinati Organics Limited | Jun 2026 | ▲ Increasing | +16,749 |
| Dr. Lal Path Labs Ltd. | Jun 2026 | ▲ Increasing | +16,000 |
| Piramal Pharma Limited | May 2026 | ▲ Increasing | +60,000 |
| Jubilant Pharmova Limited | May 2026 | ▼ Reducing | -53,799 |
| Fortis Healthcare Limited | May 2026 | ▼ Reducing | -38,553 |
| Cipla Limited | May 2026 | ▼ Reducing | -25,000 |
| Dr. Lal Path Labs Ltd. | May 2026 | ▲ Increasing | +19,500 |
| IPCA Laboratories Limited | May 2026 | ▼ Reducing | -17,000 |
| Pfizer Limited | May 2026 | ▲ Increasing | +2,500 |
| Gland Pharma Limited | May 2026 | ▲ Increasing | +517 |
| GlaxoSmithKline Pharmaceuticals Limited | May 2026 | ▼ Reducing | -407 |
| Alembic Pharmaceuticals Limited | May 2026 | ▼ Reducing | -10 |
| Dr. Lal Path Labs Ltd. | Apr 2026 | ▲ New position | +62,256 |
| IPCA Laboratories Limited | Apr 2026 | ▼ Reducing | -51,643 |
| Mankind Pharma Limited | Apr 2026 | ▲ Increasing | +30,000 |
| Anthem Biosciences Limited | Mar 2026 | ▲ New position | +0.01 Cr |
| Mankind Pharma Limited | Mar 2026 | ▲ Increasing | +25,000 |
| Procter & Gamble Health Limited | Mar 2026 | ▲ Increasing | +9,685 |
| Sanofi Consumer Healthcare India Limited | Mar 2026 | ▲ Increasing | +8,010 |
| Pfizer Limited | Mar 2026 | ▲ Increasing | +7,408 |
| Procter & Gamble Health Limited | Feb 2026 | ▲ Increasing | +6,510 |
| Sanofi Consumer Healthcare India Limited | Feb 2026 | ▲ Increasing | +2,171 |
| Piramal Pharma Limited | Jan 2026 | ▲ Increasing | +0.01 Cr |
| Cipla Limited | Jan 2026 | ▼ Reducing | -0.01 Cr |
| Shilpa Medicare Limited | Jan 2026 | ▲ Increasing | +70,000 |
| Jubilant Pharmova Limited | Jan 2026 | ▲ Increasing | +22,000 |
| Sanofi Consumer Healthcare India Limited | Jan 2026 | ▲ Increasing | +2,223 |
| Pfizer Limited | Jan 2026 | ▲ Increasing | +1,650 |
| CORONA Remedies Limited | Dec 2025 | ▲ New position | +0.01 Cr |
| Sun Pharmaceutical Industries Limited | Dec 2025 | ▲ Increasing | +75,000 |
| Shilpa Medicare Limited | Dec 2025 | ▲ Increasing | +60,000 |
| Lupin Limited | Dec 2025 | ▼ Reducing | -40,000 |
| Cipla Limited | Dec 2025 | ▼ Reducing | -40,000 |
| Alembic Pharmaceuticals Limited | Dec 2025 | ▼ Reducing | -24,237 |
| GlaxoSmithKline Pharmaceuticals Limited | Dec 2025 | ▼ Reducing | -8,200 |
| Anthem Biosciences Limited | Nov 2025 | ▼ Complete exit | -0.02 Cr |
| Aurobindo Pharma Limited | Nov 2025 | ▲ Increasing | +70,000 |
| J.B. Chemicals & Pharmaceuticals Lt | Nov 2025 | ▲ Increasing | +66,546 |
| Thyrocare Technologies Limited | Nov 2025 | ▼ Reducing | -60,000 |
| Shilpa Medicare Limited | Oct 2025 | ▲ Increasing | +0.03 Cr |
| Anthem Biosciences Limited | Oct 2025 | ▼ Reducing | -0.02 Cr |
| Fortis Healthcare Limited | Oct 2025 | ▼ Reducing | -0.01 Cr |
| Thyrocare Technologies Limited | Sep 2025 | ▲ Increasing | +6,300 |
| Pfizer Limited | Sep 2025 | ▲ Increasing | +1,500 |
| Piramal Pharma Limited | Aug 2025 | ▲ New position | +0.04 Cr |
| Sai Life Sciences Limited | Aug 2025 | ▼ Reducing | -70,000 |
| Fortis Healthcare Limited | Aug 2025 | ▼ Reducing | -50,000 |
| Aurobindo Pharma Limited | Aug 2025 | ▼ Reducing | -50,000 |
| Shilpa Medicare Limited | Aug 2025 | ▲ Increasing | +20,200 |
| Sanofi India Limited | Aug 2025 | ▼ Complete exit | -19,296 |
| Pfizer Limited | Aug 2025 | ▲ New position | +15,000 |
| Jubilant Pharmova Limited | Aug 2025 | ▲ Increasing | +14,014 |
| Thyrocare Technologies Limited | Aug 2025 | ▲ Increasing | +12,000 |
| Vinati Organics Limited | Aug 2025 | ▲ Increasing | +8,270 |
| Sanofi Consumer Healthcare India Limited | Aug 2025 | ▲ Increasing | +482 |
| Anthem Biosciences Limited | Jul 2025 | ▲ New position | +0.04 Cr |
| Akums Drugs and Pharmaceuticals Limited | Jul 2025 | ▼ Complete exit | -0.02 Cr |
| Biocon Limited | Jul 2025 | ▼ Reducing | -0.01 Cr |
| Shilpa Medicare Limited | Jul 2025 | ▲ New position | +93,282 |
| Jubilant Pharmova Limited | Jul 2025 | ▲ New position | +80,872 |
| Thyrocare Technologies Limited | Jul 2025 | ▲ Increasing | +65,000 |
| Alembic Pharmaceuticals Limited | Jul 2025 | ▼ Reducing | -54,997 |
| Cipla Limited | Jul 2025 | ▼ Reducing | -50,000 |
| Gland Pharma Limited | Jul 2025 | ▲ New position | +50,000 |
| Torrent Pharmaceuticals Limited | Jul 2025 | ▼ Reducing | -30,900 |
| GlaxoSmithKline Pharmaceuticals Limited | Jul 2025 | ▼ Reducing | -11,321 |
| Sun Pharmaceutical Industries Limited | Jul 2025 | ▼ Reducing | -5,180 |
| Abbott India Limited | Jul 2025 | ▼ Reducing | -3,361 |
| Biocon Limited | Jun 2025 | ▲ New position | +0.04 Cr |
| Thyrocare Technologies Limited | Jun 2025 | ▲ New position | +54,893 |
| GlaxoSmithKline Pharmaceuticals Limited | Jun 2025 | ▼ Reducing | -17,457 |
| Alkem Laboratories Limited | Jun 2025 | ▼ Reducing | -14,731 |
| Torrent Pharmaceuticals Limited | Jun 2025 | ▼ Reducing | -7,000 |
| Sun Pharmaceutical Industries Limited | May 2025 | ▼ Reducing | -0.01 Cr |
| Suraksha Diagnostic Limited | May 2025 | ▲ Increasing | +94,808 |
| Max Healthcare Institute Limited | May 2025 | ▲ New position | +70,000 |
| Aurobindo Pharma Limited | May 2025 | ▼ Reducing | -70,000 |
| Divi's Laboratories Limited | May 2025 | ▲ New position | +26,000 |
| Torrent Pharmaceuticals Limited | May 2025 | ▼ Reducing | -19,643 |
Changes compare consecutive month-end disclosures for this portfolio only.